Rheumatology

  • Perioperative infection: Are we sure what to focus on?
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine June 2020, 87 (6) 317-318; DOI: https://doi.org/10.3949/ccjm.87b.06020

    Which immunosuppressive drugs pose the greater danger in the perioperative period: the newer biologics or corticosteroids?

  • Rigid airway
    Masaki Itagane, MD, Hiroyuki Yano, MD, Tomoo Kishaba, MD and Mitsuyo Kinjo, MD,MPH
    Cleveland Clinic Journal of Medicine June 2020, 87 (6) 334-336; DOI: https://doi.org/10.3949/ccjm.87a.19129

    A 23-year-old woman presents with nonproductive cough and shortness of breath.

  • Is it safe to continue biologic agents during surgery in patients with inflammatory bowel disease?
    Zain Moosvi, MD, Alexander Abadir, MD, Jacqueline Duong, BS and Douglas Nguyen, MD
    Cleveland Clinic Journal of Medicine June 2020, 87 (6) 343-346; DOI: https://doi.org/10.3949/ccjm.87a.19071

    Patients taking monoclonal antibodies can continue taking them, but small-molecule drugs should be withheld.

  • Cutaneous adverse effects of biologic medications
    Selena R. Pasadyn, BA, Daniel Knabel, MD, Anthony P. Fernandez, MD, PhD and Christine B. Warren, MD, MS
    Cleveland Clinic Journal of Medicine May 2020, 87 (5) 288-299; DOI: https://doi.org/10.3949/ccjm.87a.19119

    These therapies have revolutionized medicine but come with many unique adverse effects.

  • Flu vaccine and gout attacks
    Shih-Wei Lai, MD
    Cleveland Clinic Journal of Medicine February 2020, 87 (2) 76; DOI: https://doi.org/10.3949/ccjm.87c.02003
  • Pharmacogenomics: An evolving clinical tool for precision medicine
    Jennifer K. Hockings, PharmD, PhD, Amy L. Pasternak, PharmD, Angelika L. Erwin, MD, PhD, Neil T. Mason, MBA, Charis Eng, MD, PhD and J. Kevin Hicks, PharmD, PhD
    Cleveland Clinic Journal of Medicine February 2020, 87 (2) 91-99; DOI: https://doi.org/10.3949/ccjm.87a.19073

    More than 90% of patients are thought to carry at least 1 genetic variant that should prompt a change in dosing or medication.

  • Off-label and oft-prescribed
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine December 2019, 86 (12) 766-767; DOI: https://doi.org/10.3949/ccjm.86b.12019

    When prescribing drugs for uses beyond their FDA indications, we need to explain their anticipated side effects and benefits.

  • Beyond depression: Other uses for tricyclic antidepressants
    Joanne Schneider, DNP, RN, CNP, Mary Patterson, CNP and Xavier F. Jimenez, MD, MA
    Cleveland Clinic Journal of Medicine December 2019, 86 (12) 807-814; DOI: https://doi.org/10.3949/ccjm.86a.19005

    The pharmacology of these drugs, their potential uses in conditions other than depression, and safety considerations.

  • A link between A-fib and sleep apnea is no surprise, but why?
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine November 2019, 86 (11) 706-707; DOI: https://doi.org/10.3949/ccjm.86b.11019

    The two conditions commonly coexist, and treating the sleep apnea results in better rhythm-directed outcomes in the A-fib.

  • Appropriate laboratory testing in Lyme disease
    Appropriate laboratory testing in Lyme disease
    Teny M. John, MD and Alan J. Taege, MD
    Cleveland Clinic Journal of Medicine November 2019, 86 (11) 751-759; DOI: https://doi.org/10.3949/ccjm.86a.19029

    Testing for Lyme disease is challenging and if done incorrectly can lead to unnecessary treatment.

Pages